IMTX
Immatics N.V.
$9.23
-0.45 (-4.65%)
At close · Jul 13
Market Cap
$1.28B
Shares
136,673,161
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$9.23
Open$9.53
Day$9.20–9.70
52W$5.05–12.41
Avg vol 30d451K
Short int5.4M · 4.0% float · 13.3d
Short vol56%
DataJan 2020–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 16.5 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−8%
below
Price vs 50-day avg
−11%
below
RSI (14)
40
neutral
MACD trend
Positive
52-week position
57%
mid-range
Momentum
relative strength
1-month return
+2%
trailing
6-month return
−6%
trailing
YTD return
−12%
this year
Relative strength
−14%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $10 › 200d $10 — 50d above 200d
Institutional flow
Distributing
2 of 84 funds reported for Jun 30 · net -98.7K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
3.96% of float · ▼ -4.1% MoM · 13.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
84 holders — mid 3-yr range
Squeeze score
55
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
64%
annualized · 1-yr
Max drawdown
−28%
past year
ATR
6.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−8%
Bearish
Price vs 50-day avg
−11%
Bearish
RSI (14)
40
Neutral
MACD trend
Positive
Bullish
52-week position
57%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $10 › 200d $10 — 50d above 200d
Institutional flow
Distributing
2 of 84 funds reported for Jun 30 · net -98.7K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
3.96% of float · ▼ -4.1% MoM · 13.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
84 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $5
Now $9 · 57%
52-wk high $12
vs 200-day avg -8%
vs 50-day avg -11%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IMTX
this stock
Immatics N.V.
|
$1.28B | -12.1% | — | — | 4.0% |
|
ONC
BeOne Medicines Ltd.
|
$439.30B | +0.0% | +22179.2% | 894.0 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$121.89B | +5.9% | +46.2% | 28.5 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.52B | -14.0% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$53.71B | +4.2% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IMTX | -7.6% | +1.9% | -6.1% | -8.9% | -12.1% |
| SPY | -0.3% | +1.6% | +8.3% | +0.3% | +9.9% |
| vs SPY | -7.3% | +0.3% | -14.4% | -9.2% | -22.0% |